The Radiotherapy Center Platform of Guangzhou Royallee Hospital is dedicated to delivering high-precision, personalized, and comprehensive cancer treatment solutions for patients worldwide. Supported by cutting-edge medical equipment, internationally recognized expert teams, and standardized international medical service protocols, the Center integrates advanced radiation therapy technologies with minimally invasive treatment concepts to design optimized treatment strategies for tumors of different types and stages—offering particularly innovative and precise solutions for patients with multi-lesion cancers.

Equipped with a full spectrum of state-of-the-art radiation therapy technologies, the Center has established a comprehensive technical system covering the entire continuum of oncologic care, providing a solid foundation for individualized treatment planning. The core radiation therapy modalities include:

1. Conventional Radiotherapy

As a clinically mature and widely applied foundational radiation modality, conventional radiotherapy delivers scientifically optimized radiation dose distributions precisely to tumor targets, achieving effective tumor control. It is commonly used for adjuvant postoperative treatment of various solid tumors as well as palliative management of advanced-stage malignancies. This approach can significantly reduce tumor burden, relieve pain, and improve patients’ quality of life. The Center strictly adheres to international treatment guidelines, customizing individualized dose regimens to ensure therapeutic efficacy while minimizing radiation exposure to surrounding healthy tissues.

2. Photon Therapy

Photon therapy utilizes high-energy photon beams with strong penetration capabilities to accurately target deep-seated tumors. The Center is equipped with internationally advanced three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) technologies, enabling radiation dose distributions to conform closely to tumor geometry. This significantly enhances treatment precision while reducing treatment-related toxicity. Photon therapy is widely applied in the management of common malignancies such as lung cancer, breast cancer, and head and neck tumors.

3. Gamma Knife Radiosurgery

Gamma Knife therapy is a non-invasive stereotactic radiosurgical technique that precisely focuses multiple gamma-ray beams on tumor targets, achieving highly accurate tumor ablation. With no surgical incision, minimal trauma, and rapid recovery, it is particularly suitable for small tumors, benign lesions, and metastatic tumors in the head and neck region—such as brain metastases, acoustic neuromas, and pituitary adenomas. It provides a safe and effective treatment option for patients who are not candidates for conventional surgery.

4. Stereotactic Radiotherapy (SRT)

Characterized by high precision, high-dose delivery, and hypofractionation, stereotactic radiotherapy delivers ablative radiation doses to tumor lesions within a limited number of treatment sessions. By maximizing tumor destruction while sparing surrounding normal organs, SRT offers excellent therapeutic outcomes. Combined with image-guided radiotherapy (IGRT), real-time tumor position monitoring further enhances treatment safety and accuracy. SRT is an ideal option for early-stage lung cancer, liver cancer, and recurrent or metastatic tumors.

5. Proton Therapy

As one of the most advanced radiation therapy technologies globally, proton therapy leverages the unique Bragg peak effect to concentrate radiation doses precisely within the tumor, with minimal radiation exposure beyond the target area. This significantly reduces the risk of long-term treatment-related side effects. Proton therapy is especially beneficial for tumors located near critical organs, including pediatric tumors, skull base tumors, prostate cancer, and breast cancer.

Synergistic Radiotherapy and Minimally Invasive Treatment: Precision Solutions for Multi-Lesion Cancer Patients

To address the clinical challenges of multi-lesion cancers, the Center has pioneered a synergistic treatment model integrating radiotherapy with minimally invasive interventions. Personalized comprehensive treatment strategies are developed for each patient. For individuals with multiple dispersed tumor lesions, coordinated approaches—such as minimally invasive resection of dominant lesions combined with precision radiotherapy for residual disease, or multi-target stereotactic radiotherapy integrated with interventional therapies—are employed. This strategy avoids the extensive trauma associated with traditional open surgery while enabling comprehensive coverage of multiple tumor sites, thereby improving local tumor control rates and extending patient survival.

The Radiotherapy Center Platform operates under a multidisciplinary team (MDT) model composed of international oncology specialists, radiation oncologists, medical physicists, and minimally invasive interventional experts. Each multi-lesion case undergoes joint consultation to comprehensively evaluate tumor location, size, number, and the patient’s overall condition, ensuring the formulation of the most effective synergistic treatment plan. All treatments are delivered in strict accordance with international medical standards, supported by rigorous quality assurance and standardized operational protocols to ensure safety and efficacy.

To meet the needs of international patients, the Center provides comprehensive one-stop international medical services, including multilingual consultations, personalized treatment plan explanations, cross-border medical coordination, and long-term follow-up management. We are committed to eliminating language barriers and procedural obstacles for global patients, enabling them to receive high-quality, precision oncology care in a comfortable and reassuring medical environment.

The Radiotherapy Center Platform of Guangzhou Royallee Cancer Hospital will continue to advance innovation at the intersection of radiation therapy and minimally invasive technologies, upholding international medical service standards and delivering new hope for recovery to cancer patients worldwide.